483
Biomet, Inc.Biomet, Inc. – FDA 483, Nov 9, 2023
Record Details
An FDA inspection of Biomet, Inc. in Warsaw, IN, revealed inadequate procedures for process changes, specifically concerning bioburden monitoring for Juggerstich Meniscal Repair and Juggerloc devices. The firm failed to maintain proper bioburden monitoring after a product routing deletion, resulting in the distribution of nonconforming lots. This indicates a serious lapse in quality system controls for medical device manufacturing.
View Company Profile
ID · f9ffe056-57aa-4873-ab11-bf7a5b33aceb
Other documents for Biomet, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.